Total Payments
$20,931
2024 Payments
$6,951
Companies
22
Transactions
118
Medicare Patients
7,161
Medicare Billing
$599,515
Payment Breakdown by Category
Other$18,522 (88.5%)
Food & Beverage$2,225 (10.6%)
Travel$143.57 (0.7%)
Education$40.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,522 | 9 | 88.5% |
| Food and Beverage | $2,225 | 103 | 10.6% |
| Travel and Lodging | $143.57 | 1 | 0.7% |
| Education | $40.00 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $19,528 | 58 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $243.45 | 16 | $0 (2022) |
| Eisai Inc. | $183.77 | 4 | $0 (2024) |
| Synaptive Medical Inc. | $143.57 | 1 | $0 (2018) |
| FUJIFILM Medical Systems USA, Inc. | $106.54 | 1 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $102.86 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $72.08 | 5 | $0 (2023) |
| Celgene Corporation | $61.59 | 3 | $0 (2023) |
| Allergan, Inc. | $55.87 | 4 | $0 (2022) |
| LivaNova USA, Inc. | $54.79 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,951 | 30 | ABBVIE INC. ($6,687) |
| 2023 | $12,850 | 32 | ABBVIE INC. ($12,680) |
| 2022 | $371.32 | 23 | ABBVIE INC. ($161.15) |
| 2021 | $90.46 | 5 | Biogen, Inc. ($42.88) |
| 2020 | $83.23 | 4 | PORTOLA PHARMACEUTICALS, LLC ($21.48) |
| 2019 | $60.58 | 4 | Neurocrine Biosciences, Inc. ($19.51) |
| 2018 | $346.06 | 8 | Synaptive Medical Inc. ($143.57) |
| 2017 | $178.25 | 12 | Supernus Pharmaceuticals, Inc. ($178.25) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $99.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Neurology | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Central Nervous System | ||||||
| 05/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $44.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,787 | 2,271 | $549,968 | $148,052 |
| 2022 | 22 | 1,845 | 2,387 | $563,546 | $161,561 |
| 2021 | 19 | 1,843 | 2,420 | $569,682 | $164,394 |
| 2020 | 20 | 1,686 | 1,967 | $462,075 | $125,507 |
Total Patients
7,161
Total Services
9,045
Medicare Billing
$599,515
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 553 | 748 | $191,488 | $49,028 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 199 | 215 | $59,343 | $20,893 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 224 | 224 | $74,216 | $20,549 | 27.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 139 | 238 | $34,409 | $14,141 | 41.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 102 | 185 | $14,560 | $6,684 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 132 | 143 | $25,740 | $6,347 | 24.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 138 | 143 | $30,888 | $4,830 | 15.6% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 59 | 59 | $24,047 | $4,599 | 19.1% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2023 | 22 | 52 | $20,838 | $3,982 | 19.1% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 29 | 29 | $19,186 | $3,651 | 19.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 39 | 39 | $19,242 | $3,599 | 18.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 52 | 54 | $6,894 | $2,312 | 33.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 13 | 26 | $10,324 | $2,193 | 21.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $5,975 | $1,906 | 31.9% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 16 | 16 | $4,938 | $957.44 | 19.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 15 | 15 | $3,300 | $924.45 | 28.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 22 | 52 | $2,286 | $728.14 | 31.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 18 | 18 | $2,294 | $727.94 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 607 | 842 | $195,344 | $59,014 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 210 | 210 | $73,710 | $20,328 | 27.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 129 | 239 | $37,045 | $12,727 | 34.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 125 | 127 | $37,465 | $12,498 | 33.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 53 | $22,949 | $7,811 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 150 | 163 | $26,080 | $6,989 | 26.8% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 66 | 67 | $28,609 | $5,430 | 19.0% |
About Anil Kumar
Anil Kumar is a Neurology healthcare provider based in North Platte, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/19/2013. The National Provider Identifier (NPI) number assigned to this provider is 1437589009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anil Kumar has received a total of $20,931 in payments from pharmaceutical and medical device companies, with $6,951 received in 2024. These payments were reported across 118 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,522).
As a Medicare-enrolled provider, Kumar has provided services to 7,161 Medicare beneficiaries, totaling 9,045 services with total Medicare billing of $599,515. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location North Platte, NE
- Active Since 11/19/2013
- Last Updated 06/02/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1437589009
Products in Payments
- QULIPTA (Drug) $19,257
- TROKENDI XR (Drug) $225.64
- Leqembi (Drug) $183.77
- BOTOX (Biological) $161.87
- Brightmatter Guide/Modus V (Device) $143.57
- ESD - Core Endoscopy (Device) $106.54
- NUPLAZID (Drug) $102.86
- UBRELVY (Drug) $99.57
- ZEPOSIA (Drug) $61.59
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $54.79
- DUOPA (Drug) $54.07
- VYVGART (Drug) $53.04
- Hizentra (Biological) $48.95
- VYEPTI (Biological) $45.28
- Aimovig (Biological) $38.94
- Austedo XR (Drug) $31.25
- AIMOVIG (Biological) $31.23
- QUTENZA (Drug) $26.59
- KESIMPTA (Drug) $26.52
- NURTEC ODT (Drug) $22.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.